Lei Tian
- Transplantation top 5%
- Cancer Research top 10%
- MicroRNA in disease regulation 9
- Cancer-related molecular mechanisms research 5
- Biochemistry top 10%
- Phytochemicals and Antioxidant Activities 3
- Pharmacology top 10%
-
- Liver Disease Diagnosis and Treatment 4
-
- Phytochemistry and Biological Activities 4
-
- Air Quality and Health Impacts 3
-
- Glioma Diagnosis and Treatment 3
-
- Ferroptosis and cancer prognosis 3
- Journals
- The Journal of Immunology (1 paper)Cancer Research (1 paper)Journal of Agricultural and Food Chemistry (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Lei Tian
53 papers receiving 851 citations
Peers
Comparison fields: 5 of 107
- Transplantation 56
- Cancer Research 216
- Biochemistry 41
- Molecular Biology 468
- Pharmacology 52
Countries citing papers authored by Lei Tian
This map shows the geographic impact of Lei Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Tian more than expected).
Fields of papers citing papers by Lei Tian
This network shows the impact of papers produced by Lei Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Tian. The network helps show where Lei Tian may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lei Tian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 10 | |
| 7 | 2023 | 4 | |
| 8 | 2022 | 10 | |
| 9 | 2022 | 5 | |
| 10 | 2021 | 6 | |
| 11 | 2021 | 19 | |
| 12 | 2021 | 7 | |
| 13 | 2021 | 17 | |
| 14 | 2020 | 28 | |
| 15 | 2020 | 11 | |
| 16 | 2020 | 3 | |
| 17 | 2019 | 1 | |
| 18 | 2017 | 36 | |
| 19 | 2016 | 149 | |
| 20 | 2006 | 8 |
About Lei Tian
Lei Tian is a scholar working on Cancer Research, Biochemistry and Molecular Biology, having authored 55 papers that have together received 866 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (9 papers), Cancer-related molecular mechanisms research (5 papers), Liver Disease Diagnosis and Treatment (4 papers), Phytochemistry and Biological Activities (4 papers), Air Quality and Health Impacts (3 papers), Glioma Diagnosis and Treatment (3 papers), Ferroptosis and cancer prognosis (3 papers) and Phytochemicals and Antioxidant Activities (3 papers). The work is most often cited by research in Transplantation (56 citations), Cancer Research (216 citations) and Biochemistry (41 citations). Lei Tian has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Junqiang Chen, Jinlu Liu, Zhen Wang, Guiguang Cheng, Jianxin Cao, Afsar Khan, Yaping Liu, Tianrui Zhao, B D Kahan and Kimberly L. Napoli. Their work appears in journals such as The Journal of Immunology, Cancer Research and Journal of Agricultural and Food Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.